Global statistics on alcohol, tobacco and illicit drug use: 2017 status report
Aims This review provides an up‐to‐date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of disease. Limitations in the data are also discussed, including how these can be addressed in the future. Methods Online data sources were identi...
Uloženo v:
| Vydáno v: | Addiction (Abingdon, England) Ročník 113; číslo 10; s. 1905 - 1926 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
Blackwell Publishing Ltd
01.10.2018
|
| Témata: | |
| ISSN: | 0965-2140, 1360-0443, 1360-0443 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Aims
This review provides an up‐to‐date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of disease. Limitations in the data are also discussed, including how these can be addressed in the future.
Methods
Online data sources were identified through expert review. Data were obtained mainly from the World Health Organization, United Nations Office on Drugs and Crime and Institute for Health Metrics and Evaluation.
Results
In 2015, the estimated prevalence among the adult population was 18.4% for heavy episodic alcohol use (in the past 30 days); 15.2% for daily tobacco smoking; and 3.8, 0.77, 0.37 and 0.35% for past‐year cannabis, amphetamine, opioid and cocaine use, respectively. European regions had the highest prevalence of heavy episodic alcohol use and daily tobacco use. The age‐standardized prevalence of alcohol dependence was 843.2 per 100 000 people; for cannabis, opioids, amphetamines and cocaine dependence it was 259.3, 220.4, 86.0 and 52.5 per 100 000 people, respectively. High‐income North America region had among the highest rates of cannabis, opioid and cocaine dependence. Attributable disability‐adjusted life‐years (DALYs) were highest for tobacco smoking (170.9 million DALYs), followed by alcohol (85.0 million) and illicit drugs (27.8 million). Substance‐attributable mortality rates were highest for tobacco smoking (110.7 deaths per 100 000 people), followed by alcohol and illicit drugs (33.0 and 6.9 deaths per 100 000 people, respectively). Attributable age‐standardized mortality rates and DALYs for alcohol and illicit drugs were highest in eastern Europe; attributable age‐standardized tobacco mortality rates and DALYs were highest in Oceania.
Conclusions
In 2015 alcohol use and tobacco smoking use between them cost the human population more than a quarter of a billion disability‐adjusted life years, with illicit drugs costing further tens of millions. Europeans suffered proportionately more, but in absolute terms the mortality rate was greatest in low‐ and middle‐income countries with large populations and where the quality of data was more limited. Better standardized and rigorous methods for data collection, collation and reporting are needed to assess more accurately the geographical and temporal trends in substance use and its disease burden. |
|---|---|
| AbstractList | This review provides an up-to-date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of disease. Limitations in the data are also discussed, including how these can be addressed in the future.AIMSThis review provides an up-to-date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of disease. Limitations in the data are also discussed, including how these can be addressed in the future.Online data sources were identified through expert review. Data were obtained mainly from the World Health Organization, United Nations Office on Drugs and Crime and Institute for Health Metrics and Evaluation.METHODSOnline data sources were identified through expert review. Data were obtained mainly from the World Health Organization, United Nations Office on Drugs and Crime and Institute for Health Metrics and Evaluation.In 2015, the estimated prevalence among the adult population was 18.4% for heavy episodic alcohol use (in the past 30 days); 15.2% for daily tobacco smoking; and 3.8, 0.77, 0.37 and 0.35% for past-year cannabis, amphetamine, opioid and cocaine use, respectively. European regions had the highest prevalence of heavy episodic alcohol use and daily tobacco use. The age-standardized prevalence of alcohol dependence was 843.2 per 100 000 people; for cannabis, opioids, amphetamines and cocaine dependence it was 259.3, 220.4, 86.0 and 52.5 per 100 000 people, respectively. High-income North America region had among the highest rates of cannabis, opioid and cocaine dependence. Attributable disability-adjusted life-years (DALYs) were highest for tobacco smoking (170.9 million DALYs), followed by alcohol (85.0 million) and illicit drugs (27.8 million). Substance-attributable mortality rates were highest for tobacco smoking (110.7 deaths per 100 000 people), followed by alcohol and illicit drugs (33.0 and 6.9 deaths per 100 000 people, respectively). Attributable age-standardized mortality rates and DALYs for alcohol and illicit drugs were highest in eastern Europe; attributable age-standardized tobacco mortality rates and DALYs were highest in Oceania.RESULTSIn 2015, the estimated prevalence among the adult population was 18.4% for heavy episodic alcohol use (in the past 30 days); 15.2% for daily tobacco smoking; and 3.8, 0.77, 0.37 and 0.35% for past-year cannabis, amphetamine, opioid and cocaine use, respectively. European regions had the highest prevalence of heavy episodic alcohol use and daily tobacco use. The age-standardized prevalence of alcohol dependence was 843.2 per 100 000 people; for cannabis, opioids, amphetamines and cocaine dependence it was 259.3, 220.4, 86.0 and 52.5 per 100 000 people, respectively. High-income North America region had among the highest rates of cannabis, opioid and cocaine dependence. Attributable disability-adjusted life-years (DALYs) were highest for tobacco smoking (170.9 million DALYs), followed by alcohol (85.0 million) and illicit drugs (27.8 million). Substance-attributable mortality rates were highest for tobacco smoking (110.7 deaths per 100 000 people), followed by alcohol and illicit drugs (33.0 and 6.9 deaths per 100 000 people, respectively). Attributable age-standardized mortality rates and DALYs for alcohol and illicit drugs were highest in eastern Europe; attributable age-standardized tobacco mortality rates and DALYs were highest in Oceania.In 2015 alcohol use and tobacco smoking use between them cost the human population more than a quarter of a billion disability-adjusted life years, with illicit drugs costing further tens of millions. Europeans suffered proportionately more, but in absolute terms the mortality rate was greatest in low- and middle-income countries with large populations and where the quality of data was more limited. Better standardized and rigorous methods for data collection, collation and reporting are needed to assess more accurately the geographical and temporal trends in substance use and its disease burden.CONCLUSIONSIn 2015 alcohol use and tobacco smoking use between them cost the human population more than a quarter of a billion disability-adjusted life years, with illicit drugs costing further tens of millions. Europeans suffered proportionately more, but in absolute terms the mortality rate was greatest in low- and middle-income countries with large populations and where the quality of data was more limited. Better standardized and rigorous methods for data collection, collation and reporting are needed to assess more accurately the geographical and temporal trends in substance use and its disease burden. AimsThis review provides an up‐to‐date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of disease. Limitations in the data are also discussed, including how these can be addressed in the future.MethodsOnline data sources were identified through expert review. Data were obtained mainly from the World Health Organization, United Nations Office on Drugs and Crime and Institute for Health Metrics and Evaluation.ResultsIn 2015, the estimated prevalence among the adult population was 18.4% for heavy episodic alcohol use (in the past 30 days); 15.2% for daily tobacco smoking; and 3.8, 0.77, 0.37 and 0.35% for past‐year cannabis, amphetamine, opioid and cocaine use, respectively. European regions had the highest prevalence of heavy episodic alcohol use and daily tobacco use. The age‐standardized prevalence of alcohol dependence was 843.2 per 100 000 people; for cannabis, opioids, amphetamines and cocaine dependence it was 259.3, 220.4, 86.0 and 52.5 per 100 000 people, respectively. High‐income North America region had among the highest rates of cannabis, opioid and cocaine dependence. Attributable disability‐adjusted life‐years (DALYs) were highest for tobacco smoking (170.9 million DALYs), followed by alcohol (85.0 million) and illicit drugs (27.8 million). Substance‐attributable mortality rates were highest for tobacco smoking (110.7 deaths per 100 000 people), followed by alcohol and illicit drugs (33.0 and 6.9 deaths per 100 000 people, respectively). Attributable age‐standardized mortality rates and DALYs for alcohol and illicit drugs were highest in eastern Europe; attributable age‐standardized tobacco mortality rates and DALYs were highest in Oceania.ConclusionsIn 2015 alcohol use and tobacco smoking use between them cost the human population more than a quarter of a billion disability‐adjusted life years, with illicit drugs costing further tens of millions. Europeans suffered proportionately more, but in absolute terms the mortality rate was greatest in low‐ and middle‐income countries with large populations and where the quality of data was more limited. Better standardized and rigorous methods for data collection, collation and reporting are needed to assess more accurately the geographical and temporal trends in substance use and its disease burden. Aims This review provides an up‐to‐date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of disease. Limitations in the data are also discussed, including how these can be addressed in the future. Methods Online data sources were identified through expert review. Data were obtained mainly from the World Health Organization, United Nations Office on Drugs and Crime and Institute for Health Metrics and Evaluation. Results In 2015, the estimated prevalence among the adult population was 18.4% for heavy episodic alcohol use (in the past 30 days); 15.2% for daily tobacco smoking; and 3.8, 0.77, 0.37 and 0.35% for past‐year cannabis, amphetamine, opioid and cocaine use, respectively. European regions had the highest prevalence of heavy episodic alcohol use and daily tobacco use. The age‐standardized prevalence of alcohol dependence was 843.2 per 100 000 people; for cannabis, opioids, amphetamines and cocaine dependence it was 259.3, 220.4, 86.0 and 52.5 per 100 000 people, respectively. High‐income North America region had among the highest rates of cannabis, opioid and cocaine dependence. Attributable disability‐adjusted life‐years (DALYs) were highest for tobacco smoking (170.9 million DALYs), followed by alcohol (85.0 million) and illicit drugs (27.8 million). Substance‐attributable mortality rates were highest for tobacco smoking (110.7 deaths per 100 000 people), followed by alcohol and illicit drugs (33.0 and 6.9 deaths per 100 000 people, respectively). Attributable age‐standardized mortality rates and DALYs for alcohol and illicit drugs were highest in eastern Europe; attributable age‐standardized tobacco mortality rates and DALYs were highest in Oceania. Conclusions In 2015 alcohol use and tobacco smoking use between them cost the human population more than a quarter of a billion disability‐adjusted life years, with illicit drugs costing further tens of millions. Europeans suffered proportionately more, but in absolute terms the mortality rate was greatest in low‐ and middle‐income countries with large populations and where the quality of data was more limited. Better standardized and rigorous methods for data collection, collation and reporting are needed to assess more accurately the geographical and temporal trends in substance use and its disease burden. This review provides an up-to-date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of disease. Limitations in the data are also discussed, including how these can be addressed in the future. Online data sources were identified through expert review. Data were obtained mainly from the World Health Organization, United Nations Office on Drugs and Crime and Institute for Health Metrics and Evaluation. In 2015, the estimated prevalence among the adult population was 18.4% for heavy episodic alcohol use (in the past 30 days); 15.2% for daily tobacco smoking; and 3.8, 0.77, 0.37 and 0.35% for past-year cannabis, amphetamine, opioid and cocaine use, respectively. European regions had the highest prevalence of heavy episodic alcohol use and daily tobacco use. The age-standardized prevalence of alcohol dependence was 843.2 per 100 000 people; for cannabis, opioids, amphetamines and cocaine dependence it was 259.3, 220.4, 86.0 and 52.5 per 100 000 people, respectively. High-income North America region had among the highest rates of cannabis, opioid and cocaine dependence. Attributable disability-adjusted life-years (DALYs) were highest for tobacco smoking (170.9 million DALYs), followed by alcohol (85.0 million) and illicit drugs (27.8 million). Substance-attributable mortality rates were highest for tobacco smoking (110.7 deaths per 100 000 people), followed by alcohol and illicit drugs (33.0 and 6.9 deaths per 100 000 people, respectively). Attributable age-standardized mortality rates and DALYs for alcohol and illicit drugs were highest in eastern Europe; attributable age-standardized tobacco mortality rates and DALYs were highest in Oceania. In 2015 alcohol use and tobacco smoking use between them cost the human population more than a quarter of a billion disability-adjusted life years, with illicit drugs costing further tens of millions. Europeans suffered proportionately more, but in absolute terms the mortality rate was greatest in low- and middle-income countries with large populations and where the quality of data was more limited. Better standardized and rigorous methods for data collection, collation and reporting are needed to assess more accurately the geographical and temporal trends in substance use and its disease burden. |
| Author | Farrell, Michael Larney, Sarah Ali, Robert West, Robert Rehm, Jürgen Grebely, Jason Hickman, Matthew Hall, Wayne Giovino, Gary A. Degenhardt, Louisa Colledge, Samantha Griffiths, Paul Ferrari, Alize J. Gowing, Linda Marsden, John Peacock, Amy Leung, Janni |
| Author_xml | – sequence: 1 givenname: Amy orcidid: 0000-0002-5705-2026 surname: Peacock fullname: Peacock, Amy organization: University of Tasmania – sequence: 2 givenname: Janni orcidid: 0000-0001-5816-2959 surname: Leung fullname: Leung, Janni organization: Queensland Centre for Mental Health Research – sequence: 3 givenname: Sarah orcidid: 0000-0002-5602-4963 surname: Larney fullname: Larney, Sarah organization: Brown University – sequence: 4 givenname: Samantha surname: Colledge fullname: Colledge, Samantha organization: University of New South Wales – sequence: 5 givenname: Matthew orcidid: 0000-0001-9864-459X surname: Hickman fullname: Hickman, Matthew organization: University of Bristol – sequence: 6 givenname: Jürgen orcidid: 0000-0001-5665-0385 surname: Rehm fullname: Rehm, Jürgen organization: Institute for Clinical Psychology and Psychotherapy – sequence: 7 givenname: Gary A. surname: Giovino fullname: Giovino, Gary A. organization: University at Buffalo – sequence: 8 givenname: Robert orcidid: 0000-0002-0291-5760 surname: West fullname: West, Robert organization: University College London – sequence: 9 givenname: Wayne orcidid: 0000-0003-1984-0096 surname: Hall fullname: Hall, Wayne organization: Institute of Psychiatry, Psychology and Neuroscience, King's College London – sequence: 10 givenname: Paul surname: Griffiths fullname: Griffiths, Paul organization: European Monitoring Centre on Drugs and Drug Addiction – sequence: 11 givenname: Robert orcidid: 0000-0003-2905-8153 surname: Ali fullname: Ali, Robert organization: University of Adelaide – sequence: 12 givenname: Linda orcidid: 0000-0002-9124-4056 surname: Gowing fullname: Gowing, Linda organization: University of Adelaide – sequence: 13 givenname: John orcidid: 0000-0002-1307-2498 surname: Marsden fullname: Marsden, John organization: Institute of Psychiatry, Psychology and Neuroscience, King's College London – sequence: 14 givenname: Alize J. surname: Ferrari fullname: Ferrari, Alize J. organization: Queensland Centre for Mental Health Research – sequence: 15 givenname: Jason orcidid: 0000-0002-1833-2017 surname: Grebely fullname: Grebely, Jason organization: University of New South Wales – sequence: 16 givenname: Michael orcidid: 0000-0001-7008-8130 surname: Farrell fullname: Farrell, Michael organization: University of New South Wales – sequence: 17 givenname: Louisa orcidid: 0000-0002-8513-2218 surname: Degenhardt fullname: Degenhardt, Louisa email: l.degenhardt@unsw.edu.au organization: University of Washington |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29749059$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kUtLAzEUhYMoWqsL_4AE3Cg4evOYZOJOfIPoRtchzaQaSSc1mUH67422bkSzCSTfOfdyzjZa72LnENojcELKOTVte0I4ZXwNjQgTUAHnbB2NQIm6ooTDFtrO-Q0AZKP4JtqiSnIFtRqhh5sQJybg3Jve597bjGOHTbDxNYZj3JdPayM2XYt9CN76HrdpeMFDdmeYApHfyiHj5OYx9TtoY2pCdrure4yer6-eLm6r-8ebu4vz-8ryBnhlaa0sV0ayr42cMhOgpC4vThEBdtpIQflUEEaUa1jDpBFKUicEMFATkGyMDpe-8xTfB5d7PfPZuhBM5-KQNQXWUCEFFwU9-IW-xSF1ZTtNCQChNZRBY7S_oobJzLV6nvzMpIX-SaoAp0vApphzclNdsiiZxa5PxgdNQH91oUsX-ruLojj6pfgx_YtduX_44Bb_g_r88nKp-ATsm5N4 |
| CitedBy_id | crossref_primary_10_1016_j_conctc_2025_101452 crossref_primary_10_1016_j_jpsychires_2022_11_029 crossref_primary_10_1186_s12889_024_18151_3 crossref_primary_10_1002_lio2_70244 crossref_primary_10_1080_10826084_2022_2086698 crossref_primary_10_12998_wjcc_v12_i14_2359 crossref_primary_10_1371_journal_pone_0307702 crossref_primary_10_1016_j_pnpbp_2021_110278 crossref_primary_10_1080_09687637_2021_1901856 crossref_primary_10_3389_fcvm_2021_610989 crossref_primary_10_1007_s00213_025_06895_8 crossref_primary_10_1016_j_drugalcdep_2020_108495 crossref_primary_10_1016_j_encep_2024_09_002 crossref_primary_10_1093_epirev_mxaa002 crossref_primary_10_1016_j_drugalcdep_2019_107704 crossref_primary_10_1016_j_ynirp_2024_100202 crossref_primary_10_3389_fpsyt_2022_866019 crossref_primary_10_1016_j_eujim_2020_101096 crossref_primary_10_1016_j_addbeh_2018_11_043 crossref_primary_10_1186_s40814_019_0446_1 crossref_primary_10_1111_dar_13363 crossref_primary_10_1007_s11904_021_00558_x crossref_primary_10_32388_3PDC00_2 crossref_primary_10_1007_s12024_023_00702_6 crossref_primary_10_1007_s40429_019_00245_3 crossref_primary_10_3389_fpubh_2025_1513242 crossref_primary_10_1080_16549716_2024_2341522 crossref_primary_10_1007_s11356_021_16271_6 crossref_primary_10_1186_s13722_024_00500_7 crossref_primary_10_1159_000546680 crossref_primary_10_1186_s12909_023_04858_1 crossref_primary_10_1016_j_pharmthera_2022_108212 crossref_primary_10_1016_j_neubiorev_2021_11_019 crossref_primary_10_1186_s12888_025_07123_5 crossref_primary_10_1186_s13722_024_00459_5 crossref_primary_10_1016_j_encep_2024_10_003 crossref_primary_10_1111_dar_13128 crossref_primary_10_3389_fpubh_2024_1470809 crossref_primary_10_3390_biom13050761 crossref_primary_10_3390_ijerph19063253 crossref_primary_10_1007_s10597_024_01336_w crossref_primary_10_1016_j_psychres_2021_114068 crossref_primary_10_1111_acer_13930 crossref_primary_10_1016_j_pnpbp_2019_109780 crossref_primary_10_1017_S1463423621000244 crossref_primary_10_1186_s13011_021_00350_5 crossref_primary_10_1016_j_nicl_2020_102383 crossref_primary_10_1016_j_abrep_2020_100260 crossref_primary_10_1080_14659891_2023_2199845 crossref_primary_10_1016_j_cld_2018_09_011 crossref_primary_10_1038_s41398_024_03035_2 crossref_primary_10_1039_C9FO00153K crossref_primary_10_1136_bmjopen_2022_064324 crossref_primary_10_1080_14659891_2023_2278523 crossref_primary_10_1007_s40618_020_01257_x crossref_primary_10_1080_15332640_2025_2459731 crossref_primary_10_1016_j_jpsychires_2021_02_045 crossref_primary_10_1111_add_16186 crossref_primary_10_3389_fpsyt_2022_935491 crossref_primary_10_1093_ntr_ntab109 crossref_primary_10_1186_s12889_021_11084_1 crossref_primary_10_1016_j_drugalcdep_2021_108630 crossref_primary_10_1016_j_amp_2018_08_015 crossref_primary_10_1128_Spectrum_00138_21 crossref_primary_10_1016_j_jns_2020_116763 crossref_primary_10_3389_fpsyt_2021_730153 crossref_primary_10_1080_15504263_2023_2226588 crossref_primary_10_1097_QAD_0000000000002125 crossref_primary_10_1016_j_neubiorev_2021_03_014 crossref_primary_10_1007_s00103_021_03328_7 crossref_primary_10_1007_s10654_022_00883_4 crossref_primary_10_1371_journal_pone_0252815 crossref_primary_10_3389_fnins_2021_656475 crossref_primary_10_1155_2024_3775241 crossref_primary_10_3390_gels8120768 crossref_primary_10_1002_jbt_22872 crossref_primary_10_1007_s00406_023_01635_5 crossref_primary_10_1016_j_drugalcdep_2020_108102 crossref_primary_10_3389_fpsyg_2025_1568132 crossref_primary_10_1002_sdr_1738 crossref_primary_10_1007_s11469_022_00808_y crossref_primary_10_1016_j_jss_2022_05_001 crossref_primary_10_1080_10826084_2022_2096234 crossref_primary_10_1111_dar_14002 crossref_primary_10_3390_healthcare10040669 crossref_primary_10_1007_s12144_023_04843_3 crossref_primary_10_1016_j_jff_2020_104166 crossref_primary_10_3390_ejihpe11020040 crossref_primary_10_1080_14659891_2024_2322154 crossref_primary_10_1093_ntr_ntaa020 crossref_primary_10_7759_cureus_18758 crossref_primary_10_1111_febs_15496 crossref_primary_10_1097_CORR_0000000000002465 crossref_primary_10_1016_j_arabjc_2023_104903 crossref_primary_10_3390_biomedicines12061152 crossref_primary_10_1016_j_puhip_2023_100372 crossref_primary_10_1016_j_jacasi_2021_04_007 crossref_primary_10_1093_ntr_ntad231 crossref_primary_10_1111_odi_15106 crossref_primary_10_1007_s11065_021_09506_3 crossref_primary_10_1016_j_cophys_2018_08_004 crossref_primary_10_1186_s12954_024_01015_9 crossref_primary_10_3389_ijph_2022_1605554 crossref_primary_10_1007_s10465_019_09301_x crossref_primary_10_1007_s42399_021_00871_x crossref_primary_10_3390_su13052834 crossref_primary_10_1080_14659891_2024_2395512 crossref_primary_10_1016_S2215_0366_19_30097_5 crossref_primary_10_1016_j_abrep_2021_100359 crossref_primary_10_1016_j_ijmedinf_2025_105897 crossref_primary_10_1038_s44220_023_00034_y crossref_primary_10_1186_s43045_025_00524_y crossref_primary_10_1097_OLQ_0000000000001480 crossref_primary_10_1080_14659891_2022_2155592 crossref_primary_10_1016_j_drugalcdep_2021_108858 crossref_primary_10_1111_add_16170 crossref_primary_10_1177_11782218231205840 crossref_primary_10_1186_s12887_021_02710_3 crossref_primary_10_1159_000543252 crossref_primary_10_1007_s13311_022_01229_4 crossref_primary_10_1080_10826084_2022_2040029 crossref_primary_10_1016_j_drugalcdep_2024_112424 crossref_primary_10_1016_j_pnpbp_2024_111171 crossref_primary_10_1177_09645284221125248 crossref_primary_10_3390_jcm13113057 crossref_primary_10_1007_s13644_021_00451_4 crossref_primary_10_1016_j_neubiorev_2021_02_038 crossref_primary_10_1038_s41583_022_00656_8 crossref_primary_10_1080_14659891_2024_2395528 crossref_primary_10_1177_00220345211036072 crossref_primary_10_3390_jpm12091416 crossref_primary_10_1097_PRA_0000000000000764 crossref_primary_10_1007_s00148_024_01055_2 crossref_primary_10_1097_QAD_0000000000003485 crossref_primary_10_3389_fpsyt_2023_1045111 crossref_primary_10_3390_su11205858 crossref_primary_10_1136_bmjopen_2022_062183 crossref_primary_10_1093_ntr_ntac242 crossref_primary_10_3238_arztebl_m2025_0157 crossref_primary_10_1016_j_pnpbp_2025_111383 crossref_primary_10_1080_08039488_2021_2018038 crossref_primary_10_1111_add_16384 crossref_primary_10_25259_IJMR_388_2024 crossref_primary_10_1136_bmjopen_2022_064360 crossref_primary_10_1136_bmjopen_2021_050914 crossref_primary_10_1038_s41598_024_68151_x crossref_primary_10_1093_nsr_nwae467 crossref_primary_10_1080_10550887_2020_1800891 crossref_primary_10_1016_j_scitotenv_2020_141331 crossref_primary_10_1515_ijamh_2020_0086 crossref_primary_10_1080_10826084_2024_2320375 crossref_primary_10_1093_ntr_ntab265 crossref_primary_10_1097_ADT_0000000000000240 crossref_primary_10_1016_j_jpsychires_2024_01_045 crossref_primary_10_1177_0306624X251348606 crossref_primary_10_3389_fpsyg_2022_1028375 crossref_primary_10_1016_j_addbeh_2018_08_017 crossref_primary_10_3390_ijerph18126425 crossref_primary_10_1007_s00059_024_05273_y crossref_primary_10_2196_15519 crossref_primary_10_1186_s12888_023_04663_6 crossref_primary_10_3389_fnins_2020_00467 crossref_primary_10_3390_ph16010119 crossref_primary_10_1371_journal_pone_0270307 crossref_primary_10_25259_IJTMRPH_91_2024 crossref_primary_10_1038_s41386_021_01095_2 crossref_primary_10_1111_acer_14602 crossref_primary_10_18332_tid_204253 crossref_primary_10_1007_s10389_020_01280_5 crossref_primary_10_1038_s41380_024_02620_7 crossref_primary_10_1093_police_paac095 crossref_primary_10_1186_s42238_025_00315_6 crossref_primary_10_1159_000520185 crossref_primary_10_3389_fpsyt_2019_00343 crossref_primary_10_3389_fpsyt_2025_1511575 crossref_primary_10_3389_fpsyt_2021_811032 crossref_primary_10_1016_j_drugalcdep_2024_111266 crossref_primary_10_1371_journal_pone_0320083 crossref_primary_10_3390_ijerph191610023 crossref_primary_10_1016_j_pnpbp_2019_109709 crossref_primary_10_3389_fpsyt_2022_1012850 crossref_primary_10_3390_ijerph17072610 crossref_primary_10_1016_j_dib_2023_108954 crossref_primary_10_1007_s13311_019_00824_2 crossref_primary_10_1016_j_jacc_2019_02_072 crossref_primary_10_3389_fpsyt_2024_1349565 crossref_primary_10_3390_biomedicines7010016 crossref_primary_10_1080_15622975_2018_1563721 crossref_primary_10_1111_jnc_16104 crossref_primary_10_3389_fpsyt_2021_761744 crossref_primary_10_1111_add_14753 crossref_primary_10_1186_s13148_022_01303_w crossref_primary_10_3390_nu13051612 crossref_primary_10_1016_j_drugalcdep_2018_11_017 crossref_primary_10_1016_j_jff_2019_103498 crossref_primary_10_1155_2019_8759568 crossref_primary_10_1186_s13722_025_00557_y crossref_primary_10_1016_j_jagp_2018_12_016 crossref_primary_10_3389_fmicb_2023_1241309 crossref_primary_10_3389_fped_2022_798351 crossref_primary_10_1007_s00213_025_06781_3 crossref_primary_10_1051_e3sconf_202560503010 crossref_primary_10_1097_ADT_0000000000000158 crossref_primary_10_1016_j_ijcard_2021_02_073 crossref_primary_10_3389_fpsyg_2024_1374339 crossref_primary_10_3390_nu15030637 crossref_primary_10_1111_add_14639 crossref_primary_10_1136_bmjopen_2023_072892 crossref_primary_10_1186_s12916_022_02512_z crossref_primary_10_11124_JBIES_21_00353 crossref_primary_10_1007_s12275_020_0006_7 crossref_primary_10_1016_j_envint_2021_107063 crossref_primary_10_1007_s11064_023_04093_6 crossref_primary_10_1002_brb3_70400 crossref_primary_10_1097_FTD_0000000000001104 crossref_primary_10_1371_journal_pone_0305229 crossref_primary_10_1007_s11469_020_00394_x crossref_primary_10_1016_j_jpsychires_2020_09_032 crossref_primary_10_1371_journal_pone_0309943 crossref_primary_10_1111_jfbc_13692 crossref_primary_10_1186_s42238_022_00117_0 crossref_primary_10_1016_j_ijbiomac_2022_04_131 crossref_primary_10_1186_s40814_021_00880_6 crossref_primary_10_1111_dar_14074 crossref_primary_10_1080_10826084_2019_1580295 crossref_primary_10_3389_fcvm_2022_966707 crossref_primary_10_3390_ijerph19127380 crossref_primary_10_1007_s00406_020_01155_6 crossref_primary_10_1016_j_hrthm_2025_05_062 crossref_primary_10_7759_cureus_50323 crossref_primary_10_1186_s12889_022_14416_x crossref_primary_10_3390_ijerph19053055 crossref_primary_10_1111_add_15817 crossref_primary_10_1007_s10899_022_10183_x crossref_primary_10_1038_s41598_020_57907_w crossref_primary_10_3389_fnbeh_2022_1004368 crossref_primary_10_1093_alcalc_agaa101 crossref_primary_10_1186_s12889_020_09176_5 crossref_primary_10_1016_j_addbeh_2021_107213 crossref_primary_10_3389_fnsys_2021_733898 crossref_primary_10_1038_s41597_024_03242_y crossref_primary_10_1016_j_dhjo_2024_101715 crossref_primary_10_1186_s12889_023_16830_1 crossref_primary_10_1111_adb_13315 crossref_primary_10_1007_s11864_019_0650_5 crossref_primary_10_1016_j_psychres_2020_113096 crossref_primary_10_1016_j_jhep_2022_08_030 crossref_primary_10_1177_11782218211050352 crossref_primary_10_1016_j_alcohol_2021_09_004 crossref_primary_10_1016_j_psychres_2019_05_026 crossref_primary_10_1016_j_addbeh_2021_107040 crossref_primary_10_1371_journal_pone_0224516 crossref_primary_10_1016_j_drugalcdep_2025_112559 crossref_primary_10_3390_ijerph182413130 crossref_primary_10_1016_j_abrep_2019_100229 crossref_primary_10_1186_s13063_021_05898_y crossref_primary_10_1016_j_cegh_2025_101920 crossref_primary_10_1016_j_josat_2023_209035 crossref_primary_10_1016_j_drugalcdep_2020_108177 crossref_primary_10_1186_s10194_024_01729_y crossref_primary_10_1055_a_1505_7782 crossref_primary_10_1002_nur_22367 crossref_primary_10_1038_s41398_022_01809_0 crossref_primary_10_1016_j_neubiorev_2025_106163 crossref_primary_10_1016_j_pbb_2020_173022 crossref_primary_10_1007_s00394_022_03002_x crossref_primary_10_1097_MD_0000000000035575 crossref_primary_10_1186_s13643_024_02657_3 crossref_primary_10_3390_ijms23073874 crossref_primary_10_5812_ijpbs_132616 crossref_primary_10_53941_cna_2025_100004 crossref_primary_10_1016_S2215_0366_18_30462_0 crossref_primary_10_1177_17448069221075345 crossref_primary_10_1016_j_jpsychires_2023_12_034 crossref_primary_10_3390_ijerph19010243 crossref_primary_10_3390_nu15132987 crossref_primary_10_1016_j_addbeh_2022_107578 crossref_primary_10_1093_scan_nsz077 crossref_primary_10_32628_IJSRST5241132 crossref_primary_10_1080_14659891_2023_2202748 crossref_primary_10_1111_jcpe_13892 crossref_primary_10_1016_j_addbeh_2021_107159 crossref_primary_10_1177_0091450919894341 crossref_primary_10_1080_13674676_2021_1952970 crossref_primary_10_1097_CXA_0000000000000131 crossref_primary_10_1080_14659891_2022_2077247 crossref_primary_10_1097_WNR_0000000000001495 crossref_primary_10_3389_fpsyt_2021_722240 crossref_primary_10_3390_ijms241310909 crossref_primary_10_1186_s13690_024_01491_2 crossref_primary_10_4103_indianjpsychiatry_indianjpsychiatry_672_21 crossref_primary_10_1007_s11356_021_14751_3 crossref_primary_10_1089_pop_2022_0209 crossref_primary_10_7759_cureus_56079 crossref_primary_10_1016_j_pnpbp_2020_110093 crossref_primary_10_1016_j_bbr_2020_112978 crossref_primary_10_1016_j_addbeh_2023_107864 crossref_primary_10_1016_j_lfs_2022_120964 crossref_primary_10_1136_bmjopen_2021_057707 crossref_primary_10_1111_nicc_13216 crossref_primary_10_1016_j_pnpbp_2021_110298 crossref_primary_10_3390_healthcare13101122 crossref_primary_10_1001_jama_2018_10574 crossref_primary_10_1016_j_acvd_2025_03_122 crossref_primary_10_1002_14651858_CD008940_pub3 crossref_primary_10_1097_XEB_0000000000000350 crossref_primary_10_3389_fpubh_2020_00177 crossref_primary_10_2196_22694 crossref_primary_10_1186_s13063_022_06595_0 crossref_primary_10_1080_00221325_2024_2386010 crossref_primary_10_1136_bmjsrh_2023_202140 crossref_primary_10_1038_s41598_023_46698_5 crossref_primary_10_3389_fpsyt_2025_1539611 crossref_primary_10_1080_02791072_2021_1923875 crossref_primary_10_1136_bmjopen_2024_094508 crossref_primary_10_1016_S2352_4642_20_30390_4 crossref_primary_10_3748_wjg_v31_i2_99549 crossref_primary_10_3389_fpubh_2023_929782 crossref_primary_10_1016_j_drugalcdep_2018_12_002 crossref_primary_10_1177_0022034519894963 crossref_primary_10_1111_liv_15421 crossref_primary_10_1161_CIR_0000000000000695 crossref_primary_10_1016_j_avb_2023_101891 crossref_primary_10_5694_mja2_51254 crossref_primary_10_3389_fnbeh_2025_1653783 crossref_primary_10_3389_fpsyt_2023_1231760 crossref_primary_10_1186_s12877_021_02453_x crossref_primary_10_1016_j_neubiorev_2022_104899 crossref_primary_10_1080_10826084_2023_2167495 crossref_primary_10_3389_fpsyt_2024_1233888 crossref_primary_10_1038_s41380_022_01558_y crossref_primary_10_1111_dar_13071 crossref_primary_10_1186_s12889_021_10479_4 crossref_primary_10_1007_s10826_022_02340_y crossref_primary_10_1016_j_hrtlng_2023_10_009 crossref_primary_10_3390_foods10071625 crossref_primary_10_3389_fnins_2019_01076 crossref_primary_10_15252_emmm_202216592 crossref_primary_10_1093_ije_dyab026 crossref_primary_10_11569_wcjd_v33_i7_562 crossref_primary_10_1080_16066359_2021_1884229 crossref_primary_10_3390_ijerph17218153 crossref_primary_10_7334_psicothema2022_516 crossref_primary_10_1016_j_drugpo_2023_104159 crossref_primary_10_1371_journal_pmed_1002715 crossref_primary_10_3389_fonc_2021_719355 crossref_primary_10_3389_fpubh_2023_1228632 crossref_primary_10_1186_s13063_021_05940_z crossref_primary_10_1111_add_15321 crossref_primary_10_1186_s13722_024_00474_6 crossref_primary_10_3389_fpsyt_2018_00468 crossref_primary_10_3389_fpsyt_2025_1539662 crossref_primary_10_1016_j_sajb_2024_09_069 crossref_primary_10_3390_healthcare12202012 crossref_primary_10_1186_s13011_021_00348_z crossref_primary_10_1186_s13054_020_2740_y crossref_primary_10_1038_s41380_023_02367_7 crossref_primary_10_3390_healthcare9020190 crossref_primary_10_1016_j_addbeh_2019_106128 crossref_primary_10_1089_jwh_2021_0488 crossref_primary_10_1016_j_bbi_2021_09_016 crossref_primary_10_1177_10815589231217495 crossref_primary_10_1192_bjo_2023_515 crossref_primary_10_1371_journal_pone_0255872 crossref_primary_10_1186_s13063_023_07172_9 crossref_primary_10_1016_j_jaac_2022_11_011 crossref_primary_10_1109_JSEN_2023_3284067 crossref_primary_10_1080_00221325_2022_2130025 crossref_primary_10_1177_2631831819849365 crossref_primary_10_1039_D5DD00032G crossref_primary_10_1016_j_neubiorev_2024_105603 crossref_primary_10_2147_JMDH_S460338 crossref_primary_10_3389_fpubh_2025_1577138 crossref_primary_10_1111_add_15657 crossref_primary_10_1016_j_amsu_2021_102790 crossref_primary_10_3389_fpsyt_2022_1011585 crossref_primary_10_1371_journal_pone_0309422 crossref_primary_10_2217_pmt_2021_0094 crossref_primary_10_1136_bmj_2022_072348 crossref_primary_10_3928_01484834_20200817_06 crossref_primary_10_1007_s40471_019_00215_3 crossref_primary_10_3389_fpsyt_2022_1082538 crossref_primary_10_1016_j_jpsychires_2021_12_010 crossref_primary_10_3389_fpsyt_2019_00098 crossref_primary_10_1111_dar_12979 crossref_primary_10_1007_s40121_023_00775_4 crossref_primary_10_1111_add_15424 crossref_primary_10_3389_fimmu_2022_1050876 crossref_primary_10_1016_j_ypmed_2022_107327 crossref_primary_10_3390_ijerph19127548 crossref_primary_10_1038_s41597_022_01251_3 crossref_primary_10_1177_1179173X241259603 crossref_primary_10_3389_fmed_2020_583331 crossref_primary_10_1111_dar_12972 crossref_primary_10_3389_fpsyg_2020_01426 crossref_primary_10_3389_fpsyt_2023_1129030 crossref_primary_10_1016_j_biopsycho_2025_109075 crossref_primary_10_1038_s41398_024_02996_8 crossref_primary_10_1089_can_2020_0096 crossref_primary_10_1016_j_bbr_2023_114708 crossref_primary_10_1111_add_16750 crossref_primary_10_1007_s12602_022_10005_x crossref_primary_10_1007_s40429_018_0226_7 crossref_primary_10_1016_j_chemosphere_2022_134961 crossref_primary_10_1111_adb_13398 crossref_primary_10_3389_fpubh_2024_1322574 crossref_primary_10_1007_s11606_024_08646_5 crossref_primary_10_1016_j_alcohol_2024_05_003 crossref_primary_10_1111_bph_15677 crossref_primary_10_1177_14705931231207684 crossref_primary_10_1186_s13643_018_0928_x crossref_primary_10_3389_fneur_2023_1036387 crossref_primary_10_1016_j_forsciint_2022_111412 crossref_primary_10_4102_phcfm_v13i1_2847 crossref_primary_10_1016_j_jsat_2018_08_014 crossref_primary_10_1111_add_15754 crossref_primary_10_1016_j_bios_2022_114783 crossref_primary_10_1136_bmjopen_2021_050259 crossref_primary_10_1016_j_chiabu_2022_105763 crossref_primary_10_1016_j_addbeh_2025_108376 crossref_primary_10_1016_j_pnpbp_2020_110113 crossref_primary_10_1016_j_drugalcdep_2021_109022 crossref_primary_10_1111_add_14544 crossref_primary_10_1111_add_14541 crossref_primary_10_1016_j_cjca_2021_10_008 crossref_primary_10_1136_bmjopen_2018_026375 crossref_primary_10_1007_s43678_022_00364_3 crossref_primary_10_1111_adb_13147 crossref_primary_10_1515_ijamh_2019_0157 crossref_primary_10_3390_healthcare10050909 crossref_primary_10_1016_j_jsxm_2021_11_018 crossref_primary_10_1002_wps_20735 crossref_primary_10_1017_S0033291720001919 crossref_primary_10_1016_j_pnpbp_2020_109873 crossref_primary_10_1016_j_comppsych_2019_152137 crossref_primary_10_1016_j_josat_2025_209705 crossref_primary_10_1016_j_neubiorev_2021_07_010 crossref_primary_10_1111_add_15405 crossref_primary_10_1111_add_15889 crossref_primary_10_1186_s10020_024_01013_4 crossref_primary_10_1016_j_apnu_2023_04_014 crossref_primary_10_1080_10408444_2020_1864722 crossref_primary_10_1038_s41398_019_0661_9 crossref_primary_10_1186_s13054_024_04925_z crossref_primary_10_1111_adb_13136 crossref_primary_10_1111_adb_13014 crossref_primary_10_1111_adb_13135 crossref_primary_10_1186_s12889_022_14845_8 crossref_primary_10_3389_fpsyt_2022_779239 crossref_primary_10_3390_agriculture12060842 crossref_primary_10_1007_s11469_021_00565_4 crossref_primary_10_1016_j_cld_2024_12_008 crossref_primary_10_3390_metabo12020179 crossref_primary_10_3390_jcm8081105 crossref_primary_10_1017_S003329172100386X crossref_primary_10_1111_adb_13251 crossref_primary_10_3233_WOR_230139 crossref_primary_10_1021_jasms_3c00454 crossref_primary_10_1016_j_euroneuro_2025_07_001 crossref_primary_10_1111_add_15735 crossref_primary_10_3390_nu13061824 crossref_primary_10_1111_liv_15933 crossref_primary_10_1016_j_drugalcdep_2022_109563 crossref_primary_10_5812_ijpr_130124 crossref_primary_10_1016_j_neuropharm_2024_109971 crossref_primary_10_18332_tid_157205 crossref_primary_10_1016_j_matpr_2022_07_222 crossref_primary_10_1002_lt_25647 crossref_primary_10_38124_ijisrt_25mar1082 crossref_primary_10_1016_j_ssmqr_2022_100086 crossref_primary_10_1016_j_bbrc_2024_149690 crossref_primary_10_1016_j_dr_2022_101048 crossref_primary_10_1017_S0033291721001549 crossref_primary_10_1038_s41537_022_00295_z crossref_primary_10_1111_acer_14051 crossref_primary_10_3390_children8020133 crossref_primary_10_1111_add_14650 crossref_primary_10_1176_appi_ajp_2019_19080890 crossref_primary_10_1186_s12889_024_21087_3 crossref_primary_10_1007_s11356_023_27132_9 crossref_primary_10_1016_j_drugalcdep_2021_109130 crossref_primary_10_1016_j_neurom_2022_05_005 crossref_primary_10_1136_thoraxjnl_2018_212740 crossref_primary_10_1016_j_neubiorev_2020_11_010 crossref_primary_10_1055_a_2110_1807 crossref_primary_10_1136_tobaccocontrol_2021_056723 crossref_primary_10_1016_S2215_0366_22_00339_X crossref_primary_10_1080_02791072_2024_2311143 crossref_primary_10_1055_s_0043_1768980 crossref_primary_10_1093_tbm_ibac038 crossref_primary_10_1007_s11033_021_07049_7 crossref_primary_10_3390_molecules25246057 crossref_primary_10_1016_j_jad_2020_01_141 crossref_primary_10_3389_fpubh_2023_1110435 crossref_primary_10_1111_adb_13118 crossref_primary_10_15171_hpp_2018_30 crossref_primary_10_1158_1940_6207_CAPR_22_0158 crossref_primary_10_1177_20503121221105031 crossref_primary_10_1016_j_neuro_2024_06_006 crossref_primary_10_1186_s13011_022_00467_1 crossref_primary_10_1097_JAN_0000000000000411 crossref_primary_10_3390_ijerph18157959 crossref_primary_10_3390_su142315849 crossref_primary_10_1002_jnr_24697 crossref_primary_10_1186_s13011_019_0243_0 crossref_primary_10_1111_add_15394 crossref_primary_10_1016_j_disamonth_2024_101832 crossref_primary_10_3389_fmicb_2024_1319897 crossref_primary_10_1016_j_injury_2025_112296 crossref_primary_10_3390_ijms22084090 crossref_primary_10_3390_socsci10070249 crossref_primary_10_1016_j_bbrc_2022_06_080 crossref_primary_10_1016_j_drugalcdep_2019_05_021 crossref_primary_10_3389_fpsyt_2022_1066369 crossref_primary_10_1371_journal_pone_0304948 crossref_primary_10_1111_gbb_12580 crossref_primary_10_1186_s12889_024_19250_x crossref_primary_10_1111_ecc_13699 crossref_primary_10_1093_alcalc_agae008 crossref_primary_10_3390_ijerph20021119 crossref_primary_10_1177_02601060221134139 crossref_primary_10_1016_j_drugalcdep_2019_05_003 crossref_primary_10_3390_jpm15080328 crossref_primary_10_9789_2175_5361_rpcfo_v13_10526 crossref_primary_10_1136_bmjgh_2023_014749 crossref_primary_10_1038_s41598_024_80228_1 crossref_primary_10_1056_NEJMsa2109371 crossref_primary_10_1371_journal_pone_0328135 crossref_primary_10_3389_fpsyt_2021_620489 crossref_primary_10_1007_s10896_020_00238_1 crossref_primary_10_3390_biomedicines13071516 crossref_primary_10_1176_appi_prcp_20230009 crossref_primary_10_3390_socsci10080290 crossref_primary_10_3389_fpsyt_2023_1096863 crossref_primary_10_1016_j_addbeh_2020_106556 crossref_primary_10_1016_j_tox_2023_153706 crossref_primary_10_1016_j_jpsychires_2024_02_050 crossref_primary_10_1186_s12889_022_13072_5 crossref_primary_10_18332_tid_201969 crossref_primary_10_1111_dar_13897 crossref_primary_10_1002_bdr2_1743 crossref_primary_10_1111_add_15371 crossref_primary_10_1111_dar_13778 crossref_primary_10_1111_all_15237 crossref_primary_10_1093_eep_dvz022 crossref_primary_10_1016_j_sampre_2022_100029 crossref_primary_10_1111_1471_0528_18024 crossref_primary_10_1016_j_neubiorev_2023_105038 crossref_primary_10_7759_cureus_59819 crossref_primary_10_3389_fnins_2023_1156319 crossref_primary_10_3758_s13415_023_01086_4 crossref_primary_10_1177_0890117119838101 crossref_primary_10_1016_j_pnpbp_2024_111159 crossref_primary_10_1016_j_euroneuro_2021_06_002 crossref_primary_10_3389_fnbeh_2022_831901 crossref_primary_10_5093_pi2023a16 crossref_primary_10_5498_wjp_v13_i11_893 crossref_primary_10_1016_j_pbb_2024_173827 crossref_primary_10_1016_j_scitotenv_2021_145863 crossref_primary_10_1002_jmv_25415 crossref_primary_10_1007_s40429_022_00427_6 crossref_primary_10_1080_09687637_2022_2043828 crossref_primary_10_3389_fnbeh_2023_1291128 crossref_primary_10_1111_jan_16779 crossref_primary_10_1177_0003134820945223 crossref_primary_10_1016_j_neubiorev_2021_01_019 crossref_primary_10_1097_01_NPR_0000733712_67456_43 crossref_primary_10_3389_fpls_2023_1110144 crossref_primary_10_1080_08897077_2019_1635963 crossref_primary_10_3389_fnbeh_2022_886524 crossref_primary_10_1038_s41380_025_03216_5 crossref_primary_10_1136_bmjopen_2021_054060 crossref_primary_10_2196_27774 crossref_primary_10_1038_s41366_023_01371_9 crossref_primary_10_1055_a_2338_9261 crossref_primary_10_1177_0890117119838101c crossref_primary_10_3390_antiox11071374 crossref_primary_10_3390_cancers15123103 crossref_primary_10_1007_s00406_024_01776_1 crossref_primary_10_1038_s41398_021_01200_5 crossref_primary_10_1111_add_14383 crossref_primary_10_1111_adb_70064 crossref_primary_10_1002_hbm_25114 crossref_primary_10_1038_s41598_023_47061_4 crossref_primary_10_1080_17460441_2020_1767581 crossref_primary_10_1371_journal_pone_0294587 crossref_primary_10_1080_00952990_2024_2402569 crossref_primary_10_1111_add_15111 crossref_primary_10_1111_acer_14679 crossref_primary_10_1007_s10495_023_01814_8 crossref_primary_10_1186_s12888_023_04523_3 crossref_primary_10_1007_s11011_024_01492_8 crossref_primary_10_1016_j_pedn_2023_10_034 crossref_primary_10_1007_s40429_024_00587_7 crossref_primary_10_1177_29767342251357089 crossref_primary_10_1016_j_jad_2022_12_140 crossref_primary_10_1177_21925682221093965 crossref_primary_10_1097_MD_0000000000032865 crossref_primary_10_2174_1381612826666200206091447 crossref_primary_10_1177_1178221819862283 crossref_primary_10_1007_s11469_022_00922_x crossref_primary_10_1016_j_cmet_2020_01_008 crossref_primary_10_1016_j_outlook_2020_02_001 crossref_primary_10_1111_add_16218 crossref_primary_10_2196_64861 crossref_primary_10_3390_jpm13050766 crossref_primary_10_1016_j_adcanc_2022_100075 crossref_primary_10_1016_j_bbr_2021_113438 crossref_primary_10_3389_fimmu_2019_02288 crossref_primary_10_3748_wjg_v27_i41_7080 crossref_primary_10_1093_alcalc_agab051 crossref_primary_10_1186_s13643_022_01922_7 crossref_primary_10_1186_s40359_025_02978_5 crossref_primary_10_1111_acer_14788 crossref_primary_10_1186_s12888_020_02934_0 crossref_primary_10_1080_14659891_2024_2323103 crossref_primary_10_3390_ijerph18052584 crossref_primary_10_3390_antiox9090830 crossref_primary_10_3390_ijerph19148851 crossref_primary_10_3390_ijerph16193536 crossref_primary_10_2196_38206 crossref_primary_10_1080_09638237_2023_2245902 crossref_primary_10_1136_bmjopen_2021_052819 crossref_primary_10_3390_app10196690 crossref_primary_10_1016_j_psychres_2021_113915 crossref_primary_10_1038_s41598_018_29311_y crossref_primary_10_1007_s11596_025_00113_4 crossref_primary_10_1016_j_dld_2025_07_038 crossref_primary_10_3390_healthcare11243182 crossref_primary_10_1016_j_berh_2019_03_011 crossref_primary_10_1080_00365521_2025_2554345 crossref_primary_10_1080_08897077_2021_1876200 crossref_primary_10_1080_15332640_2020_1846008 crossref_primary_10_3389_fnins_2023_1061578 crossref_primary_10_1097_JAN_0000000000000557 crossref_primary_10_1007_s00787_023_02173_0 crossref_primary_10_1016_j_mhpa_2024_100613 crossref_primary_10_1111_add_14485 crossref_primary_10_1111_add_15452 crossref_primary_10_1016_j_neuropharm_2019_107805 crossref_primary_10_1093_pm_pnac029 crossref_primary_10_1111_obr_12950 crossref_primary_10_1016_j_alcohol_2021_12_003 crossref_primary_10_1016_j_drugpo_2020_102750 crossref_primary_10_1016_j_addbeh_2021_106966 crossref_primary_10_2478_sjph_2024_0024 crossref_primary_10_1016_j_alcohol_2025_03_002 crossref_primary_10_3390_ijerph19031501 crossref_primary_10_1080_14659891_2020_1827461 crossref_primary_10_1503_jpn_210220 crossref_primary_10_3390_ijms22031249 crossref_primary_10_1016_j_neubiorev_2020_07_011 crossref_primary_10_4103_TPSY_TPSY_21_25 crossref_primary_10_3390_ijerph18041793 crossref_primary_10_3389_fcvm_2022_1042448 crossref_primary_10_3390_medicina58020322 crossref_primary_10_1038_s41572_021_00247_4 crossref_primary_10_1093_ntr_ntac079 crossref_primary_10_5964_pch_v8i1_254 crossref_primary_10_1371_journal_pone_0252853 crossref_primary_10_1016_S0140_6736_19_31789_1 crossref_primary_10_1002_bdr2_1559 crossref_primary_10_1038_s41386_025_02098_z crossref_primary_10_1080_14659891_2024_2407623 crossref_primary_10_2196_50452 crossref_primary_10_3389_fpsyt_2020_591979 crossref_primary_10_1016_j_mric_2023_12_002 crossref_primary_10_1124_pharmrev_120_000245 crossref_primary_10_1038_s41598_022_06517_9 crossref_primary_10_1146_annurev_physiol_060821_014008 crossref_primary_10_1111_ner_13410 crossref_primary_10_1177_08862605251326074 crossref_primary_10_1016_j_neubiorev_2021_09_019 crossref_primary_10_1038_s42003_023_05099_0 crossref_primary_10_1177_0269881120919970 |
| Cites_doi | 10.1016/S0140-6736(12)61766-8 10.1093/aje/kwu056 10.1111/add.12570 10.1016/S0140-6736(17)30819-X 10.1080/16549716.2017.1272882 10.1016/S2214-109X(17)30375-3 10.1111/add.12899 10.1186/1478-7954-1-4 10.1111/add.12006 10.1111/add.12185 10.1016/S0140-6736(16)31012-1 10.1177/009145090403100304 10.1186/1478-7954-8-3 10.1111/j.1465-3362.2010.00283.x 10.1111/add.14144 10.1097/COH.0000000000000041 10.1111/add.13757 10.18356/c595e10f-en 10.1016/S0140-6736(09)60746-7 10.1016/S2215-0366(16)30405-9 10.1046/j.1360-0443.2001.96689110.x 10.1111/add.12498 10.1007/s10461-017-1678-9 10.1016/S2468-2667(17)30045-2 10.1002/cpt.110 10.1016/S0140-6736(12)61085-X 10.1016/S0140-6736(11)61138-0 10.1016/S0140-6736(16)31460-X 10.1016/S2214-109X(17)30373-X |
| ContentType | Journal Article |
| Copyright | 2018 Society for the Study of Addiction 2018 Society for the Study of Addiction. |
| Copyright_xml | – notice: 2018 Society for the Study of Addiction – notice: 2018 Society for the Study of Addiction. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QG 7TK 8BJ FQK JBE K9. NAPCQ 7X8 |
| DOI | 10.1111/add.14234 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Animal Behavior Abstracts Neurosciences Abstracts International Bibliography of the Social Sciences (IBSS) International Bibliography of the Social Sciences International Bibliography of the Social Sciences ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium International Bibliography of the Social Sciences (IBSS) Neurosciences Abstracts Animal Behavior Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Social Welfare & Social Work Statistics Public Health |
| EISSN | 1360-0443 |
| EndPage | 1926 |
| ExternalDocumentID | 29749059 10_1111_add_14234 ADD14234 |
| Genre | reviewArticle Research Support, Non-U.S. Gov't Journal Article Review |
| GrantInformation_xml | – fundername: Medical Research Council grantid: G0800612 – fundername: Medical Research Council grantid: G0802736 – fundername: Department of Health grantid: 12/136/105 – fundername: Medical Research Council grantid: MR/K023195/1 – fundername: Medical Research Council grantid: MR/L022206/1 – fundername: Cancer Research UK grantid: 22962 – fundername: Medical Research Council grantid: MR/K006525/1 |
| GroupedDBID | --- ..I .3N .GA .GJ .Y3 0-V 04C 05W 0R~ 10A 1OB 1OC 23M 2QV 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6J9 6PF 702 7PT 7RV 7X7 8-0 8-1 8-3 8-4 8-5 88E 8C1 8FI 8FJ 8G5 8UM 930 A01 A03 A8Z AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABIVO ABJNI ABOCM ABPVW ABQWH ABUWG ABXGK ACAHQ ACBWZ ACCZN ACFBH ACGFO ACGFS ACGOF ACHQT ACMXC ACNCT ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADMHG ADNMO ADOJX ADOZA ADXAS ADZJE ADZMN AEFGJ AEGXH AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFNX AFFPM AFGKR AFKRA AFRAH AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHEFC AHMBA AIACR AIAGR AIDQK AIDYY AIQQE AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALSLI ALUQN ALVPJ AMBMR AMYDB AN0 ARALO ASPBG ATUGU AVWKF AZBYB AZFZN AZQEC AZVAB BAFTC BCR BCU BDRZF BEC BENPR BFHJK BGRYB BHBCM BKEYQ BLC BMSDO BMXJE BNQBC BPHCQ BROTX BRXPI BVXVI BY8 C45 CAG CCPQU COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DUUFO DWQXO DXH EAD EAP EAS EBB EBC EBD EBS EBX ECF ECT EIHBH EJD EMB EMK EMOBN EPS ESI ESTFP ESX EX3 F00 F01 F04 F5P FD6 FEDTE FUBAC FYUFA FZ0 G-S GNUQQ GODZA GUQSH H.X HF~ HGLYW HMCUK HVGLF HZI HZ~ H~9 IHE IX1 J0M J5H K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M0O M1P M2M M2O MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NAPCQ NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PCD PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PRQQA PSQYO PSYQQ PUEGO Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SJFOW SUPJJ SV3 TEORI TUS UB1 UKHRP UPT V8K V9Y W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WOHZO WOW WQ9 WQJ WVDHM WXI WXSBR XG1 XIF XOL YFH YUY ZGI ZZTAW ~IA ~WT AAYXX ABUFD AFFHD CITATION O8X ALIPV CGR CUY CVF ECM EIF NPM 7QG 7TK 8BJ FQK JBE K9. 7X8 |
| ID | FETCH-LOGICAL-c4804-c259c49a730789e9ab0215c49e9160cf87624f61319e83837a6972e660309b073 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 746 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000443932500018&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0965-2140 1360-0443 |
| IngestDate | Sun Nov 09 11:02:17 EST 2025 Sun Nov 09 14:52:28 EST 2025 Mon Jul 21 06:03:12 EDT 2025 Sat Nov 29 05:58:41 EST 2025 Tue Nov 18 21:18:58 EST 2025 Sun Sep 21 06:28:47 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Keywords | epidemiology prevalence cocaine opioid amphetamine cannabis mortality Alcohol tobacco substance dependence |
| Language | English |
| License | 2018 Society for the Study of Addiction. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4804-c259c49a730789e9ab0215c49e9160cf87624f61319e83837a6972e660309b073 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0002-0291-5760 0000-0001-7008-8130 0000-0002-1833-2017 0000-0001-5665-0385 0000-0002-8513-2218 0000-0001-9864-459X 0000-0003-2905-8153 0000-0003-1984-0096 0000-0002-1307-2498 0000-0001-5816-2959 0000-0002-5705-2026 0000-0002-5602-4963 0000-0002-9124-4056 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/add.14234 |
| PMID | 29749059 |
| PQID | 2100125061 |
| PQPubID | 37458 |
| PageCount | 22 |
| ParticipantIDs | proquest_miscellaneous_2038267646 proquest_journals_2100125061 pubmed_primary_29749059 crossref_citationtrail_10_1111_add_14234 crossref_primary_10_1111_add_14234 wiley_primary_10_1111_add_14234_ADD14234 |
| PublicationCentury | 2000 |
| PublicationDate | October 2018 |
| PublicationDateYYYYMMDD | 2018-10-01 |
| PublicationDate_xml | – month: 10 year: 2018 text: October 2018 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Abingdon |
| PublicationTitle | Addiction (Abingdon, England) |
| PublicationTitleAlternate | Addiction |
| PublicationYear | 2018 |
| Publisher | Blackwell Publishing Ltd |
| Publisher_xml | – name: Blackwell Publishing Ltd |
| References | 2017; 5 2017; 2 2017; 4 2011 2013; 108 2015; 97 2017; 21 2012; 380 2016; 388 2011; 30 2008 1993 2004 2009; 373 2017; 112 2014; 179 2004; 31 2014; 109 2000 2017; 10 2015; 110 2018 2017 2016 2015 2014 2003; 1 2014; 9 2012; 379 2017; 389 2001; 96 2010; 8 e_1_2_8_28_1 e_1_2_8_29_1 Murray C. J. L. (e_1_2_8_37_1) 2004 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 Institute for Health Metrics and Evaluation (e_1_2_8_16_1) 2016 United Nations Office on Drugs and Crime (UNODC) (e_1_2_8_11_1) 2017 United Nations General Assembly (e_1_2_8_5_1) 2015 US Department of Health and Human Services (e_1_2_8_22_1) 2014 e_1_2_8_3_1 World Health Organization (WHO) (e_1_2_8_20_1) 1993 e_1_2_8_2_1 Flaxman A. D. (e_1_2_8_24_1) 2015 e_1_2_8_4_1 e_1_2_8_7_1 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (e_1_2_8_10_1) 2011 e_1_2_8_6_1 e_1_2_8_9_1 European School Survey Project on Alcohol and Other Drugs (ESPAD) Group (e_1_2_8_12_1) 2016 e_1_2_8_8_1 American Psychiatric Association (APA) (e_1_2_8_19_1) 2000 e_1_2_8_21_1 e_1_2_8_42_1 e_1_2_8_45_1 e_1_2_8_23_1 International Agency for Research on Cancer (e_1_2_8_43_1) 2008 e_1_2_8_44_1 e_1_2_8_41_1 e_1_2_8_40_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_39_1 United Nations Office on Drugs and Crime (UNODC) (e_1_2_8_36_1) 2017 European Monitoring Centre for Drugs and Drug Addiction (e_1_2_8_13_1) 2017 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_38_1 Joint United Nations Programme on HIV/AIDS (e_1_2_8_30_1) 2014 World Health Organization (WHO) (e_1_2_8_15_1) 2016 e_1_2_8_32_1 e_1_2_8_31_1 e_1_2_8_33_1 Institute for Health Metrics and Evaluation (IHME) (e_1_2_8_34_1) 2015 |
| References_xml | – year: 2011 – year: 2018 article-title: Corrected US opioid‐involved drug poisoning deaths and mortality rates, 1999–2015 publication-title: Addiction – volume: 373 start-page: 2223 year: 2009 end-page: 2233 article-title: Global burden of disease and injury and economic cost attributable to alcohol use and alcohol‐use disorders publication-title: Lancet – volume: 379 start-page: 55 year: 2012 end-page: 70 article-title: Extent of illicit drug use and dependence, and their contribution to the global burden of disease publication-title: Lancet – volume: 380 start-page: 2224 year: 2012 end-page: 2260 article-title: A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet – volume: 9 start-page: 107 year: 2014 end-page: 114 article-title: Estimating the size of key populations: current status and future possibilities publication-title: Curr Opin HIV AIDS – volume: 110 start-page: 904 year: 2015 end-page: 919 article-title: Global statistics on addictive behaviours: 2014 status report publication-title: Addiction – volume: 5 start-page: e1192 year: 2017 end-page: e1207 article-title: Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review publication-title: Lancet Glob Health – volume: 10 year: 2017 article-title: Integrating community‐based verbal autopsy into civil registration and vital statistics (CRVS): system‐level considerations publication-title: Glob Health Action – volume: 97 start-page: 607 year: 2015 end-page: 615 article-title: Assessing the public health impacts of legalizing recreational cannabis use in the USA publication-title: Clin Pharmacol Ther – year: 2000 – volume: 108 start-page: 556 year: 2013 end-page: 565 article-title: Profiles of illicit drug use during annual key holiday and control periods in Australia: wastewater analysis in an urban, a semi‐rural and a vacation area publication-title: Addiction – volume: 112 start-page: 968 year: 2017 end-page: 1001 article-title: The relationship between different dimensions of alcohol use and the burden of disease—an update publication-title: Addiction – volume: 388 start-page: 1459 year: 2016 end-page: 1544 article-title: Global, regional, and national life expectancy, all‐cause mortality, and cause‐specific mortality for 249 causes of death, 1980‐2015: a systematic analysis for the Global Burden of Disease Study 2015 publication-title: Lancet – volume: 4 start-page: 16 year: 2017 end-page: 18 article-title: Trends in new psychoactive substances from surface and ‘dark’ net monitoring publication-title: Lancet Psychiatry – year: 2016 – volume: 109 start-page: 880 year: 2014 end-page: 893 article-title: A systematic review of the epidemiology of unrecorded alcohol consumption and the chemical composition of unrecorded alcohol publication-title: Addiction – volume: 30 start-page: 236 year: 2011 end-page: 245 article-title: Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non‐adherence and aberrant medication‐related behaviours publication-title: Drug Alcohol Rev – year: 2014 – start-page: 1 year: 2004 end-page: 38 – volume: 96 start-page: 891 year: 2001 end-page: 902 article-title: Smoking cessation and smoking patterns in the general population: a 1‐year follow‐up publication-title: Addiction – volume: 388 start-page: 1603 year: 2016 end-page: 1658 article-title: Global, regional, and national disability‐adjusted life‐years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 publication-title: Lancet – volume: 179 start-page: 1383 year: 2014 end-page: 1393 article-title: Recapture or precapture? Fallibility of standard capture‐recapture methods in the presence of referrals between sources publication-title: Am J Epidemiol – volume: 5 start-page: e1208 year: 2017 end-page: e1220 article-title: Global, regional, and country‐level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review publication-title: Lancet Glob Health – volume: 2 start-page: e166 year: 2017 end-page: e174 article-title: Implementation of key demand‐reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries: an association study publication-title: Lancet Public Health – volume: 389 start-page: 1885 year: 2017 end-page: 1906 article-title: Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015 publication-title: Lancet – volume: 108 start-page: 1529 year: 2013 end-page: 1531 article-title: Multiple parameter evidence synthesis—a potential solution for when information on drug use and harm is in conflict publication-title: Addiction – volume: 31 start-page: 467 year: 2004 article-title: Measuring alcohol consumption publication-title: Contemp Drug Probl – year: 2008 – volume: 21 start-page: 2188 year: 2017 end-page: 2206 article-title: Theoretical and empirical comparisons of methods to estimate the size of hard‐to‐reach populations: a systematic review publication-title: AIDS Behav – volume: 8 start-page: 3 year: 2010 article-title: Statistical modeling of volume of alcohol exposure for epidemiological studies of population health: the US example publication-title: Popul Health Metrics – volume: 380 start-page: 668 year: 2012 end-page: 679 article-title: Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross‐sectional household surveys publication-title: Lancet – volume: 1 start-page: 4 year: 2003 article-title: A generic model for the assessment of disease epidemiology: the computational basis of DisMod II publication-title: Popul Health Metrics – year: 2017 – volume: 109 start-page: 1338 year: 2014 end-page: 1352 article-title: Spatial differences and temporal changes in illicit drug use in Europe quantified by wastewater analysis publication-title: Addiction – year: 1993 – year: 2015 – ident: e_1_2_8_2_1 doi: 10.1016/S0140-6736(12)61766-8 – ident: e_1_2_8_31_1 doi: 10.1093/aje/kwu056 – ident: e_1_2_8_45_1 doi: 10.1111/add.12570 – volume-title: Responding to New Psychoactive Substances year: 2011 ident: e_1_2_8_10_1 – ident: e_1_2_8_28_1 doi: 10.1016/S0140-6736(17)30819-X – volume-title: GBD Results Tool year: 2016 ident: e_1_2_8_16_1 – ident: e_1_2_8_40_1 doi: 10.1080/16549716.2017.1272882 – ident: e_1_2_8_17_1 doi: 10.1016/S2214-109X(17)30375-3 – ident: e_1_2_8_6_1 doi: 10.1111/add.12899 – ident: e_1_2_8_35_1 doi: 10.1186/1478-7954-1-4 – volume-title: The ICD‐10 Classification of Mental and Behavioural Disorders—Diagnostic Criteria for Research year: 1993 ident: e_1_2_8_20_1 – ident: e_1_2_8_44_1 doi: 10.1111/add.12006 – ident: e_1_2_8_33_1 doi: 10.1111/add.12185 – ident: e_1_2_8_41_1 doi: 10.1016/S0140-6736(16)31012-1 – ident: e_1_2_8_25_1 doi: 10.1177/009145090403100304 – volume-title: ESPAD Report 2015: Results from the European School Survey Project on Alcohol and Other Drugs year: 2016 ident: e_1_2_8_12_1 – ident: e_1_2_8_26_1 doi: 10.1186/1478-7954-8-3 – ident: e_1_2_8_8_1 doi: 10.1111/j.1465-3362.2010.00283.x – ident: e_1_2_8_39_1 doi: 10.1111/add.14144 – ident: e_1_2_8_9_1 doi: 10.1097/COH.0000000000000041 – ident: e_1_2_8_38_1 doi: 10.1111/add.13757 – volume-title: IARC Handbooks of Cancer Prevention: Tobacco Control. Volume 12. Methods for Evaluating Tobacco Control Policies year: 2008 ident: e_1_2_8_43_1 – volume-title: World Drug Report 2017 year: 2017 ident: e_1_2_8_11_1 doi: 10.18356/c595e10f-en – volume-title: 90‐90‐90: An Ambitious Treatment Target to Help End the AIDS Epidemic year: 2014 ident: e_1_2_8_30_1 – ident: e_1_2_8_3_1 doi: 10.1016/S0140-6736(09)60746-7 – volume-title: Transforming Our World: the 2030 Agenda for Sustainable Development year: 2015 ident: e_1_2_8_5_1 – ident: e_1_2_8_14_1 doi: 10.1016/S2215-0366(16)30405-9 – ident: e_1_2_8_18_1 doi: 10.1046/j.1360-0443.2001.96689110.x – ident: e_1_2_8_27_1 doi: 10.1111/add.12498 – volume-title: A Protocol for the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) year: 2015 ident: e_1_2_8_34_1 – volume-title: Methodology—World Drug Report 2017. year: 2017 ident: e_1_2_8_36_1 doi: 10.18356/c595e10f-en – volume-title: Global Information System on Alcohol and Health (GISAH) year: 2016 ident: e_1_2_8_15_1 – ident: e_1_2_8_32_1 doi: 10.1007/s10461-017-1678-9 – ident: e_1_2_8_42_1 doi: 10.1016/S2468-2667(17)30045-2 – ident: e_1_2_8_7_1 doi: 10.1002/cpt.110 – volume-title: The Health Consequences of Smoking. 50 Years of Progress. A Report of the Surgeon General year: 2014 ident: e_1_2_8_22_1 – ident: e_1_2_8_29_1 doi: 10.1016/S0140-6736(12)61085-X – start-page: 1 volume-title: Comparative Quantification of Health Risks: Global and regional Burden of Disease attributable to selected major risk factors year: 2004 ident: e_1_2_8_37_1 – volume-title: European Drug Report 2017: Trends and Developments. year: 2017 ident: e_1_2_8_13_1 – volume-title: Diagnostic and Statistical Manual of Mental Disorders (DSM‐IV‐TR). year: 2000 ident: e_1_2_8_19_1 – ident: e_1_2_8_4_1 doi: 10.1016/S0140-6736(11)61138-0 – volume-title: An Integrative Metaregression Framework for Descriptive Epidemiology year: 2015 ident: e_1_2_8_24_1 – ident: e_1_2_8_21_1 doi: 10.1016/S0140-6736(16)31460-X – ident: e_1_2_8_23_1 doi: 10.1016/S2214-109X(17)30373-X |
| SSID | ssj0007894 |
| Score | 2.7043154 |
| SecondaryResourceType | review_article |
| Snippet | Aims
This review provides an up‐to‐date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of... This review provides an up-to-date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of disease.... AimsThis review provides an up‐to‐date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1905 |
| SubjectTerms | Age Alcohol Alcohol Drinking - epidemiology Alcohol related crime Alcohol use Alcoholism Alcoholism - epidemiology amphetamine Amphetamines Cannabis Cocaine Costing Crime Data collection Data quality Deaths Disability Disease Drug abuse Drug addiction Drug dependence Drug use Drugs Epidemiology Global Burden of Disease Global Health Humans Low income groups Marijuana Mortality Mortality rates Narcotics opioid Opioids People with disabilities Prevalence Public health Regions Smoking Statistics Substance abuse substance dependence Substance use Substance-Related Disorders - epidemiology Tobacco Tobacco smoking Tobacco Smoking - epidemiology Tobacco Use - epidemiology United Nations World Health Organization |
| Title | Global statistics on alcohol, tobacco and illicit drug use: 2017 status report |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fadd.14234 https://www.ncbi.nlm.nih.gov/pubmed/29749059 https://www.proquest.com/docview/2100125061 https://www.proquest.com/docview/2038267646 |
| Volume | 113 |
| WOSCitedRecordID | wos000443932500018&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Journals customDbUrl: eissn: 1360-0443 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007894 issn: 0965-2140 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS8MwED_m9MEXvz-mU6KI-GBhSz_S6NNwDh9kiCjuraRpIuJopVv9-700bVFUEHwr6aUJd_ndR9LcAZxQV2rR90NHJrF2vMTXTuxS7iQ-GmO09wyjubLYBBuPw8mE37Xgsr4LY_NDNBtuBhmlvjYAF_HsE8gRmAhz6noLsEhx3XptWBzejx5vG0XMwrIOoslv4lAMJKrEQuZHnqbzV3P0zcf86rKWNme0-q_ZrsFK5WqSgV0b69BS6QZ07X1c8qSmWuSKnJK6IctfN2FsawAQc8_IpnAmWUqEraN7Tgz6pcyISBNiNmrky5wkefFMipm6IGjlWdmzmBF7FrEFj6Prh6sbpyq54Egv7HmOxGhIelwg7pF7iovY-ATYotCN7EltdKen0QXocxWa4FYEnFEVBOakJkZ1sQ3tNEvVLpCkp6RmYax9_DDXSlCX8cSXgmqfu67bgbOa85Gs8pGbshjTqI5LkGdRybMOHDekbzYJx09E3Vp8UYXDWURNiin08oJ-B46a14ggcywiUpUVSNNzMcZigRd0YMeKvRmFYrjF0QPFyZbS_X34aDAclg97fyfdh2WUjE2v2-9Ce54X6gCW5DtKOD-EBTYJD6tF_QGI4vRC |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS8MwED90Cvri98d0ahQRHyxs6WfEF3GOiXOIKPpW0jQRcbTSrf79Xpq2KCoIvpX00oS7_O4jae4ADqktFO-4gSXiSFlO7CorsimzYheNMdp7H6O5otiEPxwGT0_sdgrOqrswJj9EveGmkVHoaw1wvSH9CeWITMQ5tZ1pmHFwGbkNmOne9R4GtSb2g6IQok5wYlGMJMrMQvpPnrrzV3v0zcn86rMWRqe3-L_pLsFC6WySc7M6lmFKJivQMjdyyaMcKZ5JckSqhjR7XYWhqQJA9E0jk8SZpAnhppLuCdH4FyIlPImJ3qoRLxMSZ_kzycfylKCd94ue-ZiY04g1eOhd3l_0rbLogiWcoO1YAuMh4TCOyEf2ScYj7RVgi0RHsi2U1p6OQiegw2Sgw1vuMZ9Kz9NnNREqjHVoJGkiN4HEbSmUH0TKxQ8zJTm1fRa7glPlMtu2m3BcsT4UZUZyXRhjFFaRCfIsLHjWhIOa9M2k4fiJqFXJLyyROA6pTjKFfp7XacJ-_RoxpA9GeCLTHGnaNkZZvud4Tdgwcq9HoRhwMfRBcbKFeH8fPjzvdouHrb-T7sFc__5mEA6uhtfbMI9SMsl2Oy1oTLJc7sCseEdpZ7vl2v4AdUT3Sg |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS8MwED90ivji98d0ahQRHyxs6WfEF3EOxTGGOPStpGkiorTSrf79Xpq2OFQQfCvppQl3-d1H0twBHFNbKN5xA0vEkbKc2FVWZFNmxS4aY7T3PkZzRbEJfzAInp7YcAYuqrswJj9EveGmkVHoaw1w-R6rLyhHZCLOqe3MwpzjMg9hOde97436tSb2g6IQok5wYlGMJMrMQvpPnrrztD365mRO-6yF0ekt_2-6K7BUOpvk0qyOVZiRyRq0zI1c8ijfFM8kOSFVQ5q9rsPAVAEg-qaRSeJM0oRwU0n3jGj8C5ESnsREb9WIlwmJs_yZ5GN5TtDO-0XPfEzMacQGjHrXD1c3Vll0wRJO0HYsgfGQcBhH5CP7JOOR9gqwRaIj2RZKa09HoRPQYTLQ4S33mE-l5-mzmggVxiY0kjSR20DithTKDyLl4oeZkpzaPotdwalymW3bTTitWB-KMiO5LozxFlaRCfIsLHjWhKOa9N2k4fiJqFXJLyyROA6pTjKFfp7XacJh_RoxpA9GeCLTHGnaNkZZvud4Tdgycq9HoRhwMfRBcbKFeH8fPrzsdouHnb-THsDCsNsL-7eDu11YRCGZXLudFjQmWS73YF58oLCz_XJpfwILPPbF |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Global+statistics+on+alcohol%2C+tobacco+and+illicit+drug+use%3A+2017+status+report&rft.jtitle=Addiction+%28Abingdon%2C+England%29&rft.au=Peacock%2C+Amy&rft.au=Leung%2C+Janni&rft.au=Larney%2C+Sarah&rft.au=Colledge%2C+Samantha&rft.date=2018-10-01&rft.eissn=1360-0443&rft.volume=113&rft.issue=10&rft.spage=1905&rft_id=info:doi/10.1111%2Fadd.14234&rft_id=info%3Apmid%2F29749059&rft.externalDocID=29749059 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0965-2140&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0965-2140&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0965-2140&client=summon |